These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1965481

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Calf-thymus topoisomerase I equilibrates metastable secondary structure subsequent to relaxation of superhelical stress.
    Brewood GP, Delrow JJ, Schurr JM.
    Biochemistry; 2010 Apr 27; 49(16):3367-80. PubMed ID: 20178373
    [Abstract] [Full Text] [Related]

  • 3. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA, Wall ME, Wani MC, Manikumar G.
    Arch Biochem Biophys; 1999 Oct 01; 370(1):66-76. PubMed ID: 10496978
    [Abstract] [Full Text] [Related]

  • 4. Topoisomerase activity associated with polyoma virus large tumor antigen.
    Marton A, Marko B, Delbecchi L, Bourgaux P.
    Biochim Biophys Acta; 1995 May 17; 1262(1):59-63. PubMed ID: 7772600
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of camptothecin on the DNA-relaxing and DNA-cleavage activity of calf thymus topoisomerase I].
    Bronshteĭn IB, Gromova II, Bukhman VL, Kafiani KA.
    Mol Biol (Mosk); 1989 May 17; 23(2):491-501. PubMed ID: 2549395
    [Abstract] [Full Text] [Related]

  • 8. Modulation of DNA topoisomerase I activity by p53.
    Gobert C, Bracco L, Rossi F, Olivier M, Tazi J, Lavelle F, Larsen AK, Riou JF.
    Biochemistry; 1996 May 07; 35(18):5778-86. PubMed ID: 8639538
    [Abstract] [Full Text] [Related]

  • 9. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
    Labourier E, Riou JF, Prudhomme M, Carrasco C, Bailly C, Tazi J.
    Cancer Res; 1999 Jan 01; 59(1):52-5. PubMed ID: 9892183
    [Abstract] [Full Text] [Related]

  • 10. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.
    Gatto B, Sanders MM, Yu C, Wu HY, Makhey D, LaVoie EJ, Liu LF.
    Cancer Res; 1996 Jun 15; 56(12):2795-800. PubMed ID: 8665516
    [Abstract] [Full Text] [Related]

  • 11. Differential modulation by spermidine of reactions catalyzed by type 1 prokaryotic and eukaryotic topoisomerases.
    Srivenugopal KS, Morris DR.
    Biochemistry; 1985 Aug 27; 24(18):4766-71. PubMed ID: 3000418
    [Abstract] [Full Text] [Related]

  • 12. A type 1 DNA topoisomerase from the kinetoplast hemoflagellate Leishmania donovani.
    Chakraborty AK, Gupta A, Majumder HK.
    Indian J Biochem Biophys; 1993 Oct 27; 30(5):257-63. PubMed ID: 8144168
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of topoisomerase I activity by tyrphostin derivatives, protein tyrosine kinase blockers: mechanism of action.
    Aflalo E, Iftach S, Segal S, Gazit A, Priel E.
    Cancer Res; 1994 Oct 01; 54(19):5138-42. PubMed ID: 7923131
    [Abstract] [Full Text] [Related]

  • 14. Purification and characterization of a type I DNA topoisomerase from calf thymus mitochondria.
    Lazarus GM, Henrich JP, Kelly WG, Schmitz SA, Castora FJ.
    Biochemistry; 1987 Sep 22; 26(19):6195-203. PubMed ID: 2825774
    [Abstract] [Full Text] [Related]

  • 15. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
    Rowe TC, Chen GL, Hsiang YH, Liu LF.
    Cancer Res; 1986 Apr 22; 46(4 Pt 2):2021-6. PubMed ID: 3004716
    [Abstract] [Full Text] [Related]

  • 16. Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.
    Riou JF, Fossé P, Nguyen CH, Larsen AK, Bissery MC, Grondard L, Saucier JM, Bisagni E, Lavelle F.
    Cancer Res; 1993 Dec 15; 53(24):5987-93. PubMed ID: 8261412
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD, Macdonald TL, Osheroff N.
    Biochemistry; 1997 Oct 21; 36(42):13095-101. PubMed ID: 9335572
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.